07:00 , Jul 9, 2009 |  BC Innovations  |  Distillery Therapeutics

Indication: Cancer

Indication Target/marker/pathway Summary Licensing status Publication and contact information Cancer Cancer Golgi phosphoprotein 3 (GOLPH3); mammalian target of rapamycin (mTOR; FRAP; RAFT1) A study in mice and in cell culture suggests that GOLPH3 could be...